A higher pulmonary vascular resistance index during exercise, but not at rest, predicts poor clinical outcomes in adults with ...
News-Medical.Net on MSN
First human 'lung-on-chip' model developed using stem cells from a single donor
Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...
It’s a simple question that physicians usually do not ask their patients: “When was your last drink?” “If the patient says yesterday, you know the patient isn’t a casual drinker,” said Joe G. Zein, MD ...
Interesting Engineering on MSN
Scientists build first breathing 'lung-on-chip' model using only one person's cells
For the first time, a breathing lung model has been made using cells from only one person. Announced on January 1, the ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
Rare inherited genetic variants significantly increase familial lung cancer risk, offering new targets for early detection.
A new study led by researchers at Wake Forest University School of Medicine, in collaboration with the University of North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback